OG0-093練習試験と学習ガイドは厳密検証された最新な365問題 [Q17-Q32]

Share

OG0-093練習試験と学習ガイドは厳密検証されたFast2test最新な365問題

2022年最新のな厳密検証された合格させるOG0-093学習ガイドベズトお試しセット


The Open Group OG0-093 認定試験の出題範囲:

トピック出題範囲
トピック 1
  • ArchiMateモデリング言語をサポートする
トピック 2
  • ArchiMate仕様の理解
トピック 3
  • コースと人員および組織の両方を評価します。

 

質問 17
Which one of the following best describes the next step in an Architecture Compliance Review once the
scope of the review has been determined?

  • A. Interview the project principals to obtain background information
  • B. Schedule the Architecture Review meeting
  • C. Send the assessment report to the Architecture Review co-ordinator
  • D. Tailor the checklists to address business requirements
  • E. Prepare the Architecture Compliance Review report

正解: D

 

質問 18
Complete the sentence. In the TOGAF Architecture Content Framework, an artifact that is a list of things is known as a _________________.

  • A. catalog
  • B. deliverable
  • C. diagram
  • D. matrix
  • E. building blocks

正解: A

 

質問 19
Scenario
Please read this scenario prior to answering the Question
You are serving as the Lead Architect for an enterprise architecture project team within a leading multinational pharmaceutical and medical devices manufacturer. Its brands include numerous household names for medications and first aid supplies.
The company has a long history of innovating new treatments for many common illnesses and diseases.
Prior to launching a new treatment, the company has to demonstrate Its effectiveness and safety in a set of clinical trials that satisfy the regulatory requirements of the countries in the target markets. All clinical trials are undertaken by its research laboratories, which employ over 10,000 people at separate facilities in the United Kingdom, United States, Sweden, France, Canada, India, China and Japan. In addition to internal research and development activities the company is also involved in publicly funded collaborative research projects, with other industrial and academic partners.
The Enterprise Architecture group within the company has been engaged in an architecture development project to create a secure networked collaboration system that will allow researchers at its product development laboratories worldwide to share information about their clinical trials. This system will also connect with external partners.
The Enterprise Architecture group within the company has been engaged in an architecture development project to create a secure networked collaboration system that will allow researchers at its product development laboratories worldwide to share information about their clinical trials. This system will also connect with external partners.
The Enterprise Architecture group is a mature organization. They use the TOGAF 9 ADM with extensions required to support current good manufacturing practices and good laboratory practices in their target markets. Due to the highly sensitive nature of the information that is managed, special care was taken to ensure that each architecture domain included an examination of the security and privacy issues that are relevant.
The Executive Vice President for Clinical Research is the sponsor of the Enterprise Architecture activity.
She has stated that the changes to the enterprise architecture for the new system will need to be rolled out in stages on a regional basis that minimizes disruptions to ongoing clinical trials.
Refer to the Scenario
You have been asked to recommend the approach to identify the work packages that will be included in the Transition Architecture(s).
Based on TOGAF, which of the following is the best answer?

  • A. Group the Solution Building Blocks from a Consolidated Gaps, Solutions and Dependencies Matrix into a set of work packages. Using the matrix as a planning tool, regroup the work packages to account for dependencies. Sequence the work packages into the Capability Increments needed to achieve the Target Architecture. Schedule the rollout one region at a time. Document the progression of the enterprise architecture using a state evolution table.
  • B. Create an Implementation Factor Assessment and Deduction Matrix and a Consolidated Gaps, Solutions and Dependencies Matrix. For each gap, identify a proposed solution and classify it as new development, purchased solution, or based on an existing product. Group similar solutions together to form work packages. Identify dependencies between work packages factoring in the clinical trial schedules. Regroup the packages into a set of Capability Increments scheduled into a series of Transition Architectures.
  • C. Use a Consolidated Gaps, Solutions and Dependencies Matrix as a planning tool. For each gap classify whether the solution is either a new development, purchased solution, or based on an existing product. Group the similar solutions together to define the work packages. Regroup the work packages into a set of Capability Increments to transition to the Target Architecture taking into account the schedule for clinical trials.
  • D. Determine the set of Solution Building Blocks required by identifying which Solution Building Blocks need to be developed and which need to be procured. Eliminate any duplicate building blocks. Group the remaining Solution Building Blocks together to create the work packages using a CRUD matrix.
    Rank the work packages in terms of cost and select the most cost-effective options for inclusion in a series of Transition Architectures. Schedule the roll out of the work packages to be sequential across the geographic regions.

正解: B

 

質問 20
Scenario:
Please read this scenario prior to answering the Question
You have been assigned the role of Lead Enterprise Architect for a firm that is a major OEM parts supplier to the auto industry. Europe has been the primary market for its products, with just 20% of its output being exported to North America. The firm is planning to expand its exports to North America and also to establish sales in South America and the Asia Pacific region. This will enable them to better ride out recessions in key markets such as Europe. It will also enable the firm to exploit the auto industry move to global platforms.
The firm is organized into business units with each addressing different auto industry sectors. Each business unit has acquired other producers to expand its manufacturing capacity. This has resulted in a complex environment with a high diversity of business and manufacturing systems.
The Enterprise Architecture (EA) program within the firm has been functioning for several years. It has made significant progress in consolidating the technology portfolio and establishing key standards. The CIO and the COO are joint sponsors of the EA program. The EA program is mature, with an active Architecture Board and a well-defined architecture process and standard content templated based on the TOGAF Architecture Content Framework. The EA program is well coordinated with the Project Management Office. Systems Development and Operations functions.
The firm has completed a strategic plan to reorganize its Sales & Marketing organization according to the target geographic markets. One of the goals of this reorganization is to improve the ability of Marketing to collect more meaningful market analytics that will enable each sector to better address market needs with effective marketing campaigns and global product presence.
A Request for Architecture Work to address the goals of the reorganization has been approved. As the architecture team commences its work, the CIO has expressed concerns about whether the firm will be able to adapt to the proposed change and how to manage the associated risks.
Refer to the Scenario.
You have been asked how to address the concerns of the CIO.
Based on the TOGAF standard, which of the following is the best answer?

  • A. In Phase A, the team should analyze their risk by completing an implementation Factor Assessment and Deduction Matrix to identify the risks associated with the implementation and deployment. The matrix should include a list of factors to be considered, their descriptions, and constraints that should be taken into account. These factors can then be used to assess the initial risks associated with the proposed project.
  • B. In Phase A, the team should evaluate the organization's readiness to undergo change. This will identify the factors that will influence the reorganization. This should include determining the readiness rating for each factor based on a maturity scale that will allow the team to gauge the urgency readiness, and degree of difficulty to fix. These factors can then be used to assess the initial risks associated with the proposed project.
  • C. In Phase A, the team should conduct a Business Scenario to describe the business problem, identify the stakeholders' concerns and the resulting requirements. Once the requirements have been identified, they can be assessed in terms of their risks. The risks should be evaluated in terms of how they could be avoided, transferred, or mitigated. Any risks that cannot be resolved should be identified as residual risks and their disposition should be decided by the Architecture Board.
  • D. In Phase B, the team should create a set of views that will enable them to identify the factors that will influence the reorganization. There should then be an assessment of each factor on a maturity scale that will allow the team to gauge the urgency, readiness, and degree of difficulty to fix. These factors can then be used to assess the initial risks associated with the proposed project.

正解: D

 

質問 21
According to TOGAF, which of the following terms is defined as the key interests that are crucially important to stakeholders?

  • A. Requirements
  • B. Views
  • C. Principles
  • D. Viewpoints
  • E. Concerns

正解: E

解説:
Section: Part 1

 

質問 22
Which pair of the following responses best completes the sentence? Architecture building blocks
____, whereas Solution Building blocks ____

  • A. are single function components; are groups of architecture building blocks
  • B. are assembled; are single function components
  • C. are reusable; are not reusable
  • D. define functionality; define the implementation of functionality
  • E. define the architecture; provide the existing legacy system

正解: D

 

質問 23
Scenario
Please read this scenario prior to answering the Question
You are serving as the Lead Architect for the enterprise architecture team at a multinational company. The company has grown rapidly by acquisition and has inherited numerous supply chain processes and related IT systems. Several supply chain processes have had problems related to the timing of purchases, which has led to excess inventory. The Vice President in charge of Supply Chain Management has made the decision to consolidate and reduce redundant processes and systems. The company will move to a "Just-in-time" supply chain management system so as to keep inventory costs low.
The TOGAF standard is used for internal Enterprise Architecture activities. This project is using an iterative approach for executing the Architecture Development Method (ADM).
At present, there are no particularly useful architectural assets in the Architecture Repository related to this initiative. All assets will need to be acquired, customized, or created.The company prefers to implement commercial off the shelf package applications with little customization. The CIO, who is the project sponsor, has stated that she is not concerned about preserving the existing supply chain management processes or systems.
The architecture development project has completed Phase A and has started a number of iteration cycles to develop the Architecture. As a packaged application is being considered, the next iteration will include both the Business, Application and Data Architectures. Key stakeholder concerns that should be addressed by these architectures include:
1. What groups of people should be involved in supply chain management-related business processes?
2. What non-supply chain management applications will need to be integrated with the new supply chain management applications?
3. What data will need to be shared?
Refer to the Scenario
[Note: You may need to refer to Chapter 35 of the reference text in order to answer this question.] You have been asked to identify the most appropriate catalogs, matrices, and diagrams to support the next iteration of Architecture development.
Based on TOGAF, which of the following is the best answer?

  • A. You would describe the Target Business Architecture with a Business Service/Function catalog, and a Business Interaction matrix. You would describe the Target Data Architecture with a Data Entity/Business Function matrix and an Application/Data matrix. You would describe the Target Application Architecture with Application Communication diagrams and an Application Interaction matrix.
  • B. You would describe the Baseline Business Architecture with a Business Service/Function catalog, an Organization/Actor catalog and a Data Entity/Business Function matrix. You would describe the Baseline Data Architecture using a Data Entity/Data Component catalog. You would describe the Baseline Application Architecture with an Application/Function matrix.
  • C. In the next iteration of Architecture development, you would describe the Baseline Business Architecture with a Value Chain diagram and a Baseline Business Process catalog. You would describe the Baseline Data Architecture with a Data diagram. You would describe the Baseline Application Architecture with an Environment and Location diagram.
  • D. In the next iteration of Architecture development, you would describe the Target Business Architecture with an Organization/Actor catalog, a Business Service/Function catalog and Data Lifecycle diagrams. You would describe the Target Application Architecture with an Application Interaction matrix and Application Communications diagrams.

正解: D

解説:
Section: Part 2

 

質問 24
TOGAF provides guidelines on how to use the ADM to establish an architecture capability. Which one of
the following is NOT a correct guideline?

  • A. Regard the establishment as an ongoing practice
  • B. Apply the ADM with the specific vision to establish the practice
  • C. Treat the establishment as a one-off project
  • D. Use the same approach as with any other capability

正解: C

 

質問 25
Which of the following is an objective of the Preliminary Phase?

  • A. Develop a vision of the proposed Enterprise Architecture
  • B. Document the baseline architecture
  • C. Obtain approval for the Statement of Architecture Work
  • D. Define the process for architecture governance
  • E. Create the initial version of the Architecture Roadmap

正解: D

解説:
Section: Part 1

 

質問 26
Which of the following are considered as generic Building Blocks in the Solutions Continuum?

  • A. Industry Solutions
  • B. Common Systems Solutions
  • C. Foundation Solutions
  • D. Organization-Specific Solutions
  • E. Strategic Solutions

正解: D

 

質問 27
Which section of the TOGAF document contains a structured metamodel for architectural artifacts?

  • A. Part VI: TOGAF Reference Models
  • B. Part VII: Architecture Capability Framework
  • C. Part II: Architecture Development Method
  • D. Part IV: Architecture Content Framework
  • E. Part III: ADM Guidelines and Techniques

正解: D

 

質問 28
Scenario:
Please read this scenario prior to answering the Question
You are serving as the Lead Architect for an enterprise architecture project team within a leading medical device manufacturer that specializes in miniature devices. The latest product under development is a tiny wireless device that can be implanted in the brain and can deliver a precise electric shock when the wearable Pain Control Unit (PCU) detects an increase in stress induced by the onset of a migraine headache.
This technology will be a breakthrough in the treatment of this condition, and several competitors are striving to be the first to introduce a product into the market. However, all of them must demonstrate the effectiveness and safety of their products in a set of clinical trials that will satisfy the regulatory requirements of the countries in the target markets.
The Enterprise Architecture group within the company has been engaged in an architecture development project to create a secure networked collaboration system that will allow researchers at its product development laboratories worldwide to share information about their independent clinical trials.
The Enterprise Architecture group is a mature organization that has been utilizing TOGAF for several years. They use the TOGAF 9 ADM with extensions required to support current good manufacturing practices and good laboratory practices in their target markets. Due to the highly sensitive nature of the information that is managed, special care was taken to ensure that each architecture domain included an examination of the security and privacy issues that are relevant for each domain. A corresponding Security Architecture has been defined.
The Executive Vice President for Clinical Research is the sponsor of the Enterprise Architecture activity. She has stated that the changes to the enterprise architecture for the new system will need to be rolled out on a geographic basis that will minimize disruptions to ongoing clinical trials. The work will need to be done in stages and rolled out in geographical regions.
Refer to the Scenario
You have been asked to recommend the approach to identify the work packages that will be included in the Transition Architecture(s).
Based on TOGAF 9, which of the following is the best answer?

  • A. Group the Solution Building Blocks from a Consolidated Gaps, Solutions and Dependencies Matrix into a set of work packages. Using the matrix as a planning tool, regroup the work packages to account for dependencies. Sequence the work packages into the Capability Increments needed to achieve the Target Architecture. Schedule the rollout one region at a time. Document the progression of the enterprise architecture using a state evolution table.
  • B. Determine the set of Solution Building Blocks required by identifying which Solution Building Blocks need to be developed and which need to be procured. Eliminate any duplicate building blocks. Group the remaining Solution Building Blocks together to create the work packages using a CRUD matrix. Rank the work packages in terms of cost and select the most cost-effective options for inclusion in a series of Transition Architectures. Schedule the roll out of the work packages to be sequential across the geographic regions.
  • C. Create an Implementation Factor Assessment and Deduction Matrix and a Consolidated Gaps, Solutions and Dependencies Matrix. For each gap, identify a proposed solution and classify it as new development, purchased solution, or based on an existing product. Group similar solutions together to form work packages. Identify dependencies between work packages factoring in the clinical trial schedules. Regroup the packages into a set of Capability Increments scheduled into a series of Transition Architectures.
  • D. Use a Consolidated Gaps, Solutions and Dependencies Matrix as a planning tool. For each gap classify whether the solution is either a new envelopment, purchased solution, or based on an existing product. Group the similar solutions together to define the work packages. Regroup the work packages into a set of Capability Increments to transition to the Target Architecture taking into account the schedule for clinical trials.

正解: D

 

質問 29
Which of the TOGAF architecture development phases is the first phase of an architecture development cycle, defines the scope for an engagement and identifies the stakeholders?

  • A. Architecture Vision
  • B. Technology Architecture
  • C. Preliminary Phase
  • D. Architecture Change Management
  • E. Business Architecture

正解: A

 

質問 30
What document is used to initiate a TOGAF ADM cycle?

  • A. Architecture Roadmap
  • B. Architecture Landscape
  • C. Request for Architecture Work
  • D. Architecture Vision
  • E. Statement of Architecture Work

正解: C

解説:
Section: Part 2

 

質問 31
Which section of the TOGAF template for Architecture Principles should highlight the business benefits for adhering to the principle?

  • A. Rationale
  • B. Name
  • C. Implications
  • D. Statement

正解: C

 

質問 32
......

究極のガイドはOG0-093最新時間限定今すぐダウンロード!:https://jp.fast2test.com/OG0-093-premium-file.html

2022年最新のな厳密検証された合格できるOG0-093試験にはリアル問題と解答:https://drive.google.com/open?id=1MqVQuLQZzL-KULhJ416mZ62ZOL3Sagfj


弊社を連絡する

我々は12時間以内ですべてのお問い合わせを答えます。

我々の働いている時間: ( GMT 0:00-15:00 )
月曜日から土曜日まで

サポート: 現在連絡 

English Deutsch 繁体中文 한국어